skip to main content, skip to Quick links, or skip to Search

Neurology

Contact Information

Phone: 919.513.6692
Fax:     919.513.6714
Email: vhcneurology@ncsu.edu
Hours: Monday-Friday, 8AM-5PM
New patient non-emergency appointments are on Monday & Wednesday mornings. Appointments by referral only.

General Information

The Terry Center

red Cross Cadeceus

Emergency Service

Main Number: 919.513.6500
Small Animal Emergency: 919.513.6911
Large Animal Emergency: 919.513.6630
Hours:
Monday-Thursday 5PM-8AM
Friday 5PM-Monday 8AM

Open 24 hours on legal holidays.
No appointment needed.

Neurology

Brain Tumors in Dogs and Cats

Cancer affecting the brain is not uncommon in older dogs and cats, although the need for advanced imaging of the brain (such as magnetic resonance imaging, or MRI) in order to detect a brain tumor means that they frequently go undiagnosed. There is also a concerning trend for brain tumors to arise in young dogs of certain breeds, such as the Boxer or the Boston terrier. Developing a brain tumor has serious implications and many owners feel helpless when such a diagnosis is made for their pet. However, these tumors vary widely in their level of malignancy and some can be treated effectively. Unfortunately, there is still a lot that we do not yet know about how different types of brain tumor behave in dogs and cats, and this can make it difficult to advise owners as to the best form of treatment for their pet. This web page provides information on what we do know about the diagnosis, treatment and prognosis of different types of brain tumor and describes ongoing research efforts at North Carolina State University College of Veterinary Medicine.

What is a brain tumor?

Strictly speaking, the term brain tumor simply means a mass in the brain. However, it is commonly used to describe a cancerous (or neoplastic) mass inside the cranial cavity (figure 1). Brain tumors may be primary, arising from the cells of the brain and its lining (figure 2), or secondary, arising elsewhere and spreading to the brain.

 

 

 


Illustrations of the major cell types
Figure 1:
Illustrations of the major cell types that give rise to brain tumors in dogs and cats.

 

 

 

 

image showing different divisions of the brain

Figure 2: The image on the left shows how the brain is divided into supra and infratentorial regions. The different divisions of the brain are shown in the image on the right.

Primary brain tumors seen in dogs and cats include meningioma, glioma, choroid plexus papilloma, pituitary adenoma or adenocarcinoma, and others.

Meningioma - This is the most common primary brain tumor in dogs and cats (and in humans). It arises from the arachnoid mater of the meninges (the membranes that line the brain, figure 2) rather than the cells of the brain itself. As such, meningiomas are not strictly brain tumors, but tend to be grouped with them because they arise within the cranial cavity and compress or invade the brain. Figure 3 is a MRI of a meningioma. These tumors occur more commonly in long nosed (doliochocephalic) breeds of dog, such as the Golden retriever. Meningiomas are usually relatively slow growing and amenable to treatment, although more malignant forms do occur.

MRI of the brain of an 8 year old female German Shepherd dog
Figure 3:
Sagittal MRI of the brain of an 8 year old female German Shepherd dog. The dog presented to its veterinarian because she had a seizure. The image of the left is a T1 weighted image after intravenous contrast agent has been adminstered. The contrast agent leaks out of abnormal blood vessels, such as those found in tumors, causing the tumor to 'light up' on MR images. The tumor can be seen as a lighter colored (contrast enhanced), well encapsulated mass in the olfactory bulb and frontal cortex of the brain (arrowhead). This appearance is typical of a meningioma and this diagnosis was confirmed when the tumor was removed surgically. The image on the right is a T2 weighted image of the same dog. On this type of image, fluid shows up white and it shows clearly how fluid (edema) tends to accumulate around a tumor (arrows). This dog was treated by surgical removal of the tumor followed by radiation, and is currently doing well.

Glioma - These tumors arise from the supporting cells of the brain (figure 2) and include astrocytomas, oligodendrogliomas, glioblastoma multiforme and ependymomas. They are common in certain breeds of dog, in particular breeds with short noses (brachycephalic breeds) such as the Boxer, the Boston terrier, and the French and English bulldog. Figure 4 shows a MRI of a glioma. Gliomas can range in malignancy from low grade and slow growing, to high grade, poorly differentiated malignant tumors (known as glioblastoma multiforme).

MRI of a 6 year old boxer
Figure 4:
Transverse T1 weighted MRI of a 6 year female old Boxer. This dog developed increased thirst, a change in personality and seizures. A large cystic tumor is present in the thalamus. Intravenous contrast agent has been administered highlighting the tumor (arrow). The tumor itself has produced fluid making a cyst (*) within the brain. The location of the tumor, within the substance of the brain, rather than on the surface, makes a glioma the most likely diagnosis. A CT guided biopsy was performed both to obtain a diagnosis, and to remove the excess free fluid from the cystic structure. The biopsy diagnosis was an oligodendroglioma (a type of glioma) and the excess fluid was removed without problem. The dog is currently being treated with chemotherapy.

Choroid plexus papilloma - Tumors of the choroid plexus (figure 2) are relatively common in dogs. Due to their cell of origin, they tend to arise within the ventricular system and can block drainage of CSF, thus a small tumor can cause very severe neurologic signs. Figure 5 shows a CT scan of one of these tumors.

CT image of a brain
Figure 5:
Transverse contrast enhanced CT image of the brain of a 5-year-old male mixed breed dog. There is a large contrast enhancing mass (arrow) lying in one of the lateral ventricles causing obstruction of cerebrospinal fluid drainage. As a result, the other lateral ventricle (V) is dilated. A sample of the tumor was taken by CT guided biopsy and confirmed the diagnosis of choroid plexus papilloma.

Pituitary adenoma or adenocarcinoma - The pituitary gland lies beneath the forebrain and is connected by a stalk to an area of the brain called the hypothalamus. Pituitary tumors (adenomas) are common in dogs and cause hyperadrenocorticism (Cushing's disease). Usually they do not cause any other neurologic signs and remain outside the actual cranial cavity. In some cases, however, they expand rapidly and compress the overlying brain. These tumors are known as pituitary macroadenomas (figure 6), or adenocarcinomas (if more malignant). There are several other more unusual tumor types that may be seen in this area such as the suprasellar germ cell tumor.

CT image of the brain of a 7 year old Labrador retriever
Figure 6:
Transverse contrast enhanced CT image of the brain of a 7-year-old male Labrador Retriever who developed non-specific pain and profound depression. A large contrast enhancing mass can be seen lying on the floor of the cranial cavity and compressing the overlying brain (arrow). The location and appearance of the mass is consistent with a pituitary mass. The diagnosis of a pituitary adenocarcinoma was confirmed at necropsy.

Others - There are many other forms of brain tumors that can be encountered more rarely.

Secondary brain tumors

Secondary tumors represent spread (metastasis) of another tumor to the brain from elsewhere in the body. Examples of tumors that may spread to the brain include hemangiosarcoma, mammary carcinoma and melanoma. These tumors carry a very poor prognosis because they have already spread through the body. It is routine practice to take radiographs of the thorax and even to ultrasound the abdomen to check there is no evidence of cancer elsewhere in the body whenever a diagnosis of a brain tumor has been made or is suspected.

What signs do brain tumors cause?

Brain tumors cause signs by compressing or invading the brain. The resulting signs relate directly to the area of the brain affected and are not specific to a tumor: any disease affecting that area of the brain could produce similar signs. As a general rule, brain tumors cause progressive signs in older animals. Signs may start very suddenly or quite insidiously, and they can wax and wane in severity.

The Forebrain - The forebrain is responsible for "thinking," behavior, and final integration of sensory information. Tumors in the forebrain may therefore cause:

The Brainstem - The brainstem plays various vital roles including regulation of motor function (the ability to walk), the level of wakefulness, and the respiratory and cardiovascular systems. The sense of balance originates in the brain stem. The brain stem is also the source of the nerves that control movement of and sensation to the face, the eyes, the throat, larynx and tongue, and the muscles of mastication (figure 7). Tumors in the brainstem can be rapidly fatal if, for example, they affect the control of breathing, but typically the first signs of brainstem disease are a loss of balance (vestibular signs), and weakness on one side of the body. There can be a wide variety of additional signs such as difficulty swallowing, change in voice and inability to move the eyes. Further progression of the signs can result in paralysis, coma and death.


Figure 7:
This is Kasey, a 10-year-old female Golden retriever. She has lost muscle mass on one side of her head (arrow) due to a trigeminal nerve root tumor. The trigeminal nerve provides sensation to the face and motor function to the muscles of mastication. Growth of the tumor gradually compresses the nerve causing the loss of muscle mass and loss of sensation. Eventually the tumor gets large enough to compress the brain. Kasey lived happily for 15 months with no special treatment of her tumor.

Vestibular signs include:

The Cerebellum - The cerebellum controls coordination of movements and interacts closely with the vestibular system to control balance and posture. Signs of cerebellar disease include:

How is a brain tumor diagnosed?

A brain tumor should be suspected whenever there is new onset of neurological signs in an animal older than 5 years. It is important to understand, that with rare exceptions, brain tumors are tumors of the soft tissues of the brain and they cannot be seen on radiographs of the skull. The brain can be imaged using magnetic resonance imaging (MRI) or computed tomographic (CT) scans. The following diagnostic steps are recommended:

  1. Complete physical and neurological examination to identify any other health problems and to localize the neurological signs to a particular area of the brain
  2. Routine blood work to rule out a systemic problem and assess the anesthetic risk
  3. Thoracic radiographs to check there is no evidence of spread (metastasis) of cancer to the lungs (a common site of metastasis)
  4. CT or MRI of the brain. This has to be done under general anesthesia. As a general rule, MRI shows the brain in more detail than CT and is the test of choice when assessing for brain tumors. However, it is a more expensive test and less widely available. CT images will identify most meningiomas and choroid plexus papillomas but can fail to identify gliomas. CT images also have a lot of artifact when trying to assess the brainstem and cerebellum. We therefore strongly recommend an MRI if the animal has signs of brainstem or cerebellar disease, or if it is a breed of dog that is predisposed to gliomas, such as the Boston Terrier.
  5. Tumor type can be suspected from the appearance of the mass on CT or MRI, but can only be definitively identified by taking a sample of the tumor, either at surgery or by biopsy. Indeed, masses caused by infections (for example abscesses or fungal granulomas) can look like brain tumors on brain images (figure 8). It is therefore vital that a sample of the tumor is taken and examined with a microscope to identify the cell types involved. Not only will this identify the tumor type, but it will also grade the malignancy of the tumor. Many neurologists, particularly those working in university teaching hospitals, routinely perform CT guided biopsies of tumors.


Figure 8:
A transverse contrast enhanced CT image of the brain of a male cat. There is a contrast enhancing lesion in the area of the cerebellum (arrow) that was found to be the result of a fungal infection of the brain.

How are brain tumors treated and what is their prognosis?

The options for treating brain tumors include surgical removal, radiation therapy, chemotherapy, and palliative treatment of the symptoms. Unfortunately, we have relatively little data to present on the outcome of tumors because it is common for owners to decide not to treat their pet, or because pets are treated with radiation therapy or chemotherapy without ever determining the tumor type. This mentality is changing as CT guided biopsies become more routinely offered, and one of our research aims is to generate a large data base of how different tumors respond to different types of treatment, and what happens if they are not treated at all (see research).

Brain tumors present unique problems related to their location and the tissue that they affect. Firstly they arise in the restricted space of the cranial cavity (Figure 1). The cranial cavity is formed by the bones of the skull and encloses and protects the brain. While a delicate structure like the brain must be protected in this way, it means there is no room for anything else within the cavity and when a tumor grows, it compresses the surrounding brain. Secondly, brain tissue cannot regenerate, and therefore removal of normal brain tissue surrounding a tumor can have unacceptable repercussions for the patient.

Surgical Removal - The aim of surgical removal of a brain tumor is either to cure the disease by complete removal (which only occurs rarely) or to alleviate the clinical signs by decompressing the brain. This can be life saving if the mass is very large. Brain tumors can be removed surgically if they are located in a site that can be reached safely. There are two considerations for this, firstly, how close is the tumor to the surface of the brain and secondly, how close is the tumor to critical areas of the brain. Tumors of the brainstem pose problems on both of these fronts. They are difficult to access because of the thick bone surrounding them, their location close to the floor of the cranial cavity, and because the brainstem does not have much redundancy of function so damaging it could be fatal. In contrast, there is much more functional redundancy in the forebrain: you can resect certain parts of the forebrain without long-term effects. Meningiomas tend to be located on the surface of the brain and are therefore the best candidates for surgical removal. Gliomas are more difficult to remove because they lie deep within the substance of the brain.

Radiation Therapy - We do know that radiation will slow the rate of growth of most types of brain tumor. The full dose of radiation is administered in fractions, the number and timing of which vary between veterinary institutions. At NCSU, we administer 16 small doses of radiation on consecutive days (with breaks for the weekend). Because the brain cannot tolerate large doses of radiation, the total dose is limited and side effects are usually minimal. It is common to see a change in hair color in the area irradiated (Figure 9), and other side effects depend on the area that is being irradiated. For example, if the ear is included in the radiation field, there may be some irritation of the ear canal (rather like an ear infection) that will resolve once the course of radiation is completed. In order to complete a course of radiation safely, the animal must be healthy enough to have a general anesthetic for each dose of radiation. Therefore, if the animal has a very large mass, it is preferable to surgically remove as much of it as possible first, thus decompressing the brain and enabling the animal to survive the course of radiation. The cost of radiation varies geographically, but is usually in the region of $3000-4000. Radiation is currently the treatment of choice for gliomas.


Figure 9:
This is Siah, a 10-year-old female Labrador Retriever who has undergone surgery and radiation of a meningioma. Her coat has changed color in the radiation field, but she has not suffered any other side effects from her treatment.

Chemotherapy - The brain is protected from circulating substances in the blood by a barrier called the blood brain barrier (BBB) and this barrier limits the effectiveness of chemotherapeutic agents. As a result, chemotherapy has not been advocated all that often for treatment of canine and feline brain tumors and we have very little if any data on the efficacy of such drugs in our patients. However, some drugs, such as the alkylating agents lomustine (CCNU), carmustine (BCNU) and a more recently developed drug, temozolomide, can cross the BBB and may be effective when treating gliomas. Recently, temozolomide has shown to be effective for this purpose in people although there is no data in dogs as yet. Chemotherapy is a reasonable alternative when treating a glioma if radiation is not an option. Drugs like CCNU can be administered once every three weeks in tablet form at home by the owner. There are dose limiting side effects on the liver and bone marrow and therefore, must be monitored closely by the attending veterinarian while receiving treatment. Recently, drugs such as 5-hydroxyurea have been used to treat meningiomas, but as yet there are no data on the efficacy of this approach.

Pallative Treatment - If none of the above therapies are an option, it is possible to treat the signs caused by a brain tumor. For example, any dog with a brain tumor that has seizures will be placed on an anti-epileptic drug such as Phenobarbital. Tumors tend to cause the accumulation of fluid (edema) around them and this can be treated with a corticosteroid such as prednisone. As many of the clinical signs can be due to the edema, some animals show a dramatic improvement within 24 hours of starting treatment with prednisone. This response is often short lived as the tumor itself is not being treated by this drug, but can certainly give owners and pets some good quality time.

Prognosis -It is important to understand that most brain tumors can be treated but not cured. Thus the major aim of treatment is to extend a good quality of life for as long as possible. Another critical point is to understand exactly what is meant when data on efficacy of treatment is presented. Useful terms include:

It is fair to say that we have little solid data on the outcome of different tumor types. There are several studies looking at the effectiveness of radiation for treating brain tumors, but in most instances, the actual tumor type was not known. As a general rule, however, median survivals of around a year are obtained when a brain tumor is irradiated. Better survivals may be obtained when treating meningiomas with surgery followed by radiation, particularly meningiomas in cats. There are some general guidelines that can be applied to individual animals when considering prognosis.

With your help, we hope that we will be able to generate much more specific and useful data on how different types of brain tumor respond to different therapies (see research below).

Current Research

Drs. Natasha Olby and Matthew Breen from the Neurology and Canine Genomics groups at the NCSU College of Veterinary Medicine, respectively, are conducting research into brain tumors in dogs with several different aims.

Project 1: The outcome of canine brain tumors with and without treatment

Project objectives - This project aims to collect the baseline data on outcome of dogs with specific types of brain tumor that will enable us to determine whether a particular treatment is effective.

Background - Currently, we know very little about how long a dog survives with the different types and grades of a brain tumor when they are not treated versus when they are treated with radiation therapy, surgery or chemotherapy. This makes it very difficult to advise owners on what will happen if they do not choose to treat their pet's brain tumor, and on what the most appropriate treatment would be if they do chose treatment. In addition, the lack of baseline data makes it very difficult to determine whether a new treatment is improving the outcome.

Methods - Every dog that is diagnosed with a brain tumor at NCSU, no matter what, if any, treatment it is given, is entered into this study with the owner's permission. The neurology research technician, Kim Williams, then contacts the owners once a month by e-mail or by telephone to monitor progress. Ideally, when the dog eventually dies or is euthanized, we arrange for a necropsy to be performed here at NCSU. This is particularly important in dogs in which a definitive diagnosis was not reached by taking a sample of the tumor, so that we can determine the actual tumor type. This approach allows us to collect information on health problems that occur related to the brain tumor during treatment, and the final data on duration of survival. As long as we get a definitive diagnosis, we will be able to compile data on the normal survival of dogs with certain types of brain tumor when not treated, or when receiving a range of different treatments. Over time, this will become an extremely valuable resource that will allow prediction of prognosis and selection of the most appropriate treatment for each case.

Benefits of the study - This is a relatively simple study for owners as their participation is limited to responding to our questions and giving regular updates. Although there is no direct benefit for the dog, many owners find this regular contact is a source of support during a difficult time. Many owners also get comfort from knowing that they are helping to generate data that should benefit dogs in the future.

Project 1: Update

In the last two years, we have recruited 62 cases to this project. Owners have been wonderful about answering our monthly telephone calls and e-mails. We do find that many people decide not to pursue an autopsy to get a specific diagnosis once the time for euthanasia arrives. We understand that this can be a difficult and painful decision to make, but we encourage them to consider this because we cannot learn more about survival unless we know what exact tumor type each dog is suffering from. Kim Williams can be contacted on kimberly_williams@ncsu.edu to discuss how to arrange an autopsy.

Project 2: The Genomics of canine brain tumors

Funded by the Canine Health Foundation of the American Kennel Club (CHF grant number 249)

Project objectives - The aims of this project are to identify genetic aberrations that are associated with canine brain tumors, and to relate these aberrations to the development of specific tumor types, response to therapy and final outcome.

Background - Cell division and cell death are controlled by a large number of different genes. It therefore makes sense that mutations in these genes could result in either uncontrolled cellular division or limited cell death. If both of these events are combined, cells may go into a cycle of repeated division and the excess cells may fail to die, resulting in a cancerous growth. In people it is well known that there are certain mutations that are associated with specific brain tumor types, and that these mutations predict how malignant the tumor is and sometimes even predict whether a tumor will respond to chemotherapy or radiation therapy . We hypothesize that similar mutations exist in dogs with brain tumors. We also hypothesize that certain dogs may have an inherited predisposition to develop brain tumors. This would explain why we see specific types of brain tumors in certain breeds of dogs.

Methods - Dogs that are undergoing surgical removal of their brain tumor, having a CT guided biopsy of their brain tumor, or are being euthanized as a result of their brain tumor are candidates for this project.

In order to look at the genetics underlying brain tumors in dogs, we have to extract cells and genetic material from a small sample of the brain tumor itself and from a sample of blood. Therefore, we need to take a sample of blood and two small, fresh samples of the brain tumor, one that we freeze immediately for extraction of DNA and RNA and the other that we use to derive tumor cells and chromosome preparations. The genes being expressed by the brain tumor are investigated using a technique called microarray analysis. This technique allows a large number of genes to be evaluated very quickly, using RNA isolated from the tumor tissue. The gene expression profile is then compared with normal controls and genes that are abnormally over or under-expressed are investigated further. We use the DNA from the tumors to perform another type of microarray analysis called Comparative Genomic Hybridization (CGH), which allows us to evaluate the whole canine genome for large regions of DNA copy number abnormalities. These abnormalities are common in human cancers and many have diagnostic and/or prognostic significance. By identifying recurrent chromosome abnormalities in canine brain tumors, we hope to be able to correlate these with prognoses and thus offer owners more information about their dogs particular case.

Project 2 : Update

In the last 2 years we have recruited 31 cases for this project. Analysis of both DNA and RNA is well underway. In view of this excellent case recruitment, all funds for supporting surgery are now exhausted and we can no longer offer financial support to owners. We are still recruiting cases and in particular have a need for more gliomas in this project.

Contact Information

If you either suspect your dog has a brain tumor, or it has already been diagnosed with a brain tumor and you would like to come to the NC State University Veterinary Health Complex for further evaluation or treatment by the neurology service, please ask your veterinarian to contact the neurology service at 919.513.6692 to make a referral. Click here for

If you would like further information on either of these studies, please contact:

Natasha Olby (clinical questions)
Telephone: 919.513.8286
Email: natasha_olby@ncsu.edu

Kim Williams
Telephone: 919.513.7235
Email:kimberly_williams@ncsu.edu

Matthew Breen (molecular biology questions)
Email: matthew_breen@ncsu.edu

If you are interested in making a donation towards this research, please contact the North Carolina Veterinary Medical Foundation.